Ardelyx Inc (ARDX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $776.74M
Last updated: Nov 17, 2026 at 4:41 PM ET
Ardelyx Inc (ARDX) Statistics
Ardelyx (ARDX) has a market cap of $776.74M and an enterprise value of $982.78M. Its share count is up 3.35% from a year earlier. It kept -11.85% of revenue as net income over the last 12 months.
Total Valuation
Enterprise value is 26.53% above the market cap, as debt exceeds cash.
| Market Cap | $776.74M |
|---|---|
| Enterprise Value | $982.78M |
| Latest price (Nov 17, 2026) | $3.18 |
Key Dates
| Last Earnings Date | Nov 3, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.7x and 4.8x. Its year-end P/S ranged from 3.5x to 93.2x from 2017 to 2025.
| P/S Ratio | 1.7x |
|---|---|
| Forward P/S | 1.6x |
| P/B Ratio | 4.8x |
Price Statistics
The stock is down 45.73% over 52 weeks and trades 2.15% below its 50-day average.
| Beta (1Y) | 0.89 |
|---|---|
| 52-Week Change | -45.73% |
| 1-Month Change | +2.91% |
| 3-Month Change | -21.09% |
| 6-Month Change | -47.78% |
| 5-Year Change | +150.41% |
| 10-Year Change | -75.37% |
| Total Return (1Y) | -45.73% |
| Total Return (3Y CAGR) | -9.78% |
| Return vs SPY (1Y) | -56.83% |
| Max Drawdown (1Y) | -63.95% |
| Max Drawdown (3Y) | -70.43% |
| Sharpe Ratio (1Y) | -1.04 |
| Correlation with SPY (1Y) | 0.21 |
| 50-Day Average | $3.25 |
| 200-Day Average | $5.06 |
| 52-Week Range | $2.80 to $8.40 |
| RSI (14 Days) | 52.0 |
| Average Volume (20 Days) | 4.76M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 3.45x current liabilities, and total debt is 1.54x shareholder equity.
| Current Ratio | 3.45x |
|---|---|
| Quick Ratio | 3.26x |
| Debt / Equity | 1.54x |
| Interest Coverage | -0.97x |
Returns and Efficiency
Return on invested capital is -6.52% over the last 12 months, against a 5-year average of -29.20%.
| Return on Equity (ROE) | -33.81% |
|---|---|
| Return on Assets (ROA) | -9.44% |
| Return on Invested Capital (ROIC) | -6.52% |
| Return on Capital Employed (ROCE) | -5.91% |
| ROE (5Y Average) | -71.78% |
| ROA (5Y Average) | -36.87% |
| ROIC (5Y Average) | -29.20% |
| Asset Turnover | 0.87x |
| Inventory Turnover | 1.03x |
| Receivables Turnover | 4.83x |
| Cash Conversion Cycle | -78 days |
Scores
ARDX has an Altman Z-Score of 0.02, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 0.02 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $468.22M over the last 12 months is up 17.57% from the 12 months before.
| Revenue | $468.22M |
|---|---|
| Revenue Growth (YoY) | +17.57% |
| Gross Profit | $442.26M |
| Operating Income | -$36.10M |
| Pretax Income | -$55.26M |
| Net Income | -$55.47M |
| EBITDA | -$17.12M |
| EBIT | -$27.16M |
| Reported EPS (TTM) | -$0.23 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 27.92% of the $587.52M in total assets.
| Cash and Equivalents | $46.32M |
|---|---|
| Total Debt | $252.36M |
| Net Debt | $206.04M |
| Net Debt Per Share | $0.82 |
| Working Capital | $313.58M |
| Shareholder Equity | $164.05M |
| Book Value Per Share | $0.66 |
| Total Assets | $587.52M |
| Total Liabilities | $423.48M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$15.51M |
|---|---|
| FCF Per Share | -$0.06 |
| Depreciation and Amortization | $10.04M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -7.71%.
| Gross Margin | 94.46% |
|---|---|
| Operating Margin | -7.71% |
| Pretax Margin | -11.80% |
| Net Margin | -11.85% |
| EBITDA Margin | -3.66% |
| EBIT Margin | -5.80% |
| Gross Margin (5Y Average) | 88.61% |
Growth
Revenue grew 98.40% a year over 3 years.
| Revenue Growth (3Y CAGR) | +98.40% |
|---|---|
| Revenue Growth (5Y CAGR) | +121.90% |
| Book Value Per Share Growth (2Y CAGR) | -5.08% |
| Tangible Book Per Share Growth (2Y CAGR) | -5.08% |
Dividends and Yields
ARDX does not pay a dividend.
| Buyback Yield | -1.09% |
|---|---|
| Shareholder Yield | -1.09% |
Peer Position
Against 8 similar companies, ARDX has the lowest P/S.
P/S RatioPeer median 7.6x
ROICPeer median -65.95%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +15.80%
| P/S Ratio | 1.7x vs 7.6x median |
|---|---|
| ROIC | -6.52% vs -65.95% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +17.57% vs +15.80% median |
Analyst Forecast
Consensus estimates put revenue growth at 22.18% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +22.18% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ARDX
What is ARDX's market cap?
Ardelyx has a market cap of $776.74M. Its enterprise value, which adds debt and subtracts cash, is $982.78M.
How many shares of ARDX are outstanding?
Ardelyx has 250.01M shares outstanding. The count is up 3.35% from a year earlier.
Does ARDX pay a dividend?
No. Ardelyx does not pay a dividend.
How much debt does ARDX have?
Ardelyx has $252.36M of total debt and $46.32M of cash and equivalents, a net debt position of $206.04M.
ARDX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts